Surgery Partners (SGRY)
(Delayed Data from NSDQ)
$33.69 USD
+5.05 (17.63%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $33.75 +0.06 (0.18%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SGRY 33.69 +5.05(17.63%)
Will SGRY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SGRY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SGRY
Surgery Partners (SGRY) Meets Q2 Earnings Estimates
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?
SGRY: What are Zacks experts saying now?
Zacks Private Portfolio Services
SGRY or MEDP: Which Is the Better Value Stock Right Now?
SGRY vs. MEDP: Which Stock Is the Better Value Option?
Wall Street Analysts Think Surgery Partners (SGRY) Could Surge 57.53%: Read This Before Placing a Bet
Other News for SGRY
Surgery Partners jumps after report of interest from UnitedHealth, TPG
What You Missed on Wall Street On Friday
UnitedHealth, TPG among suitors for Surgery Partners, Bloomberg says
TPG, UNH expressed interest in buying Surgery Partners, Bloomberg says
Surgery Partners up 14% to $32.62 after Bloomberg says UNH among bidders